NTLA News and Press, Intellia Therapeutics Inc. From 02/26/26

Evertec Inc. (EVTC) is expected to report $0.81 for Q4 2025 BioCryst Pharmaceuticals Inc. (BCRX) is expected to report $0.06 for Q4 2025 FTI Consulting Inc. (FCN) is expected to report $1.38 for Q4 2025 Arbe Robotics Ltd. (ARBE) is expected to report $-0.1 for Q4 2025 Aclaris Ther...

2026-02-25 09:51:59 ET More on Intellia Therapeutics Intellia Therapeutics: 2 Major Catalysts Will Determine Stock's Trajectory In 2026 Intellia Therapeutics: Maintaining A Sell Rating As Platform Risks Escalate Intellia Therapeutics, Inc. (NTLA) Presents at 44th Ann...

CAMBRIDGE, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that management will be participating in the upcoming investor conferences...

2026-02-23 14:34:32 ET More on CRISPR Therapeutics, Intellia Therapeutics Crispr Therapeutics: Very High Risk, But Even Higher Potential Reward CRISPR Therapeutics AG (CRSP) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript Crispr: Emphasis Shifts...

2026-02-19 12:45:02 ET Intellia Therapeutics Inc. (NASDAQ: NTLA) , a Cambridge, Massachusetts–based CRISPR gene-editing biotechnology company, is experiencing elevated short-selling activity, with approximately 45.3 million shares sold short as of the Jan. 30, 2026 settlement dat...

CAMBRIDGE, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the company will host a conference call on February 26, 2026, at 8 a....

2026-02-17 09:35:22 ET More on short interest Most shorted large-cap stocks in January Least shorted large-cap stocks in January Quantum computing stocks see elevated bearish bets amid volatility Most and least shorted large cap tech stocks in January ...

2026-02-16 13:05:27 ET More on short interest report Most and least shorted mid-to mega-cap healthcare stocks in January Hims & Hers short interest climbs amid legal risk related to weight loss pill HE, OTTR draw highest short interest in utilities sector; BIP an...

2026-02-16 07:40:00 ET Cathie Wood’s ARK Invest ETFs continued a similar trend from the last week, rotating further into crypto-linked platforms, fintech, and gene-editing names while trimming exposure to software, digital advertising, and consumer internet names.... Read t...

2026-02-12 22:37:04 ET This article is part of a series that provides an ongoing analysis of the changes made to ARK Invest’ 13F portfolio on a quarterly basis. It is based on their regulatory 13F Form filed on 02/11/2026.... Read the full article on Seeking Alpha ...